Equity benchmarks extended their downtrend for a third straight session on July 22, accompanied by weakening market breadth. On the NSE, about 2,120 shares came under pressure, while 875 shares advanced. The market is likely to witness further weakness in the near term amid rising oil prices and escalating geopolitical tensions. Below are some short-term trading ideas to consider:Rupak De, Senior ...

Here is the list of top 10 stocks that will be in focus todayTech Mahindra: IT services firm Tech Mahindra on Monday reported a consolidated net profit of Rs1,132 crore for the quarter ended June 30, 2022, as compared to Rs1,353.20 crore in the corresponding period of the last year, registering a year-on-year decline of 16.4%. On a sequential basis, the company's profit slumped by 24.8%. The compa...

Indian equity markets are likely to open gap-up on Tuesday amid mixed global cues. Nifty futures were trading 44.5 points, or 0.28% higher at 15,888 on the Singapore Exchange, signaling that Dalal Street was headed for a positive start. “Since markets are closely following global cues, the rebound in the US market is giving hope for some respite on the domestic front as well. However, we recomme...

Indian equity markets are likely to extend gains on Thursday as trends on SGX Nifty indicated a positive start for BSE Sensex, Nifty 50. The Nifty futures were trading around 17,283.50 level on the Singaporean Exchange. Global cues were positive as Asian markets were trading higher tracking positive US markets after the US Federal Reserve hiked interest rates. “Markets will first react to the ...

GlaxoSmithKline Pharmaceuticals’s (GSKP) has announced the sale of its Vemgal plant located in Karnataka to Hetero Labs Ltd for a cash consideration of Rs1.8bn. Post discontinuation of Zinetac last year this plant remained unutilized and GSKP had announced a write-off on it. Company’s recent financial performance was healthy led by recovery in its key brands and supported by recently launched ...